Susoctocog alfa Terminated Phase 3 Trials for Hemophilia As Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02895945BAX 802 in CHA With Inhibitors